Monitoring: Clinicians typically track melatonin rhythm, cortisol patterns, inflammatory markers (hs-CRP), and in some cases, telomere length via commercial testing as a baseline and follow-up tool
doi: 10.1038/s41467-021-22938-y 44 Conde-PrezK.BuetasE.Aja-MacayaP.Martin-De ArribasE.Iglesias-CorrsI.Trigo-TasendeN.et al
30 , 31 It is important to note that while direct comparison of the effect sizes of these studies was not feasible due to disparities in factors such as patient attributes, study configuration, and various followup durations, the robustness of the impact of semaglutide on glycemic status remained evident
Nicolas S, Blasco H, Bigot A, et al
& Bell, J
Ozempic is indicated for glycemic control and cardiovascular risk reduction in patients with type II diabetes, while Wegovy is indicated for weight loss